Philip J. Blower mainly investigates Nuclear medicine, Positron emission tomography, Stereochemistry, Copper and Conjugate. His Nuclear medicine research is multidisciplinary, incorporating elements of Prostate, Radiation therapy and Copper-64. Philip J. Blower has researched Copper-64 in several fields, including Chinese hamster ovary cell, Radiopharmacology, Targeted Radiotherapy, Radiobiology and Copper Radioisotopes.
His Positron emission tomography research integrates issues from Pathology, Magnetic resonance imaging, Molecular imaging and Medical imaging. Philip J. Blower has included themes like Crystallography, Alkylation, Molecule and Metal in his Stereochemistry study. Philip J. Blower works mostly in the field of Nanocapsules, limiting it down to concerns involving Imaging agent and, occasionally, Chelation.
His primary scientific interests are in Stereochemistry, Radiochemistry, Pathology, Biodistribution and Nuclear medicine. His study in Stereochemistry is interdisciplinary in nature, drawing from both Chelation, Ligand, Crystal structure, Rhenium and Combinatorial chemistry. His study looks at the relationship between Chelation and topics such as Tris, which overlap with Bifunctional.
His Radiochemistry research includes elements of Labelling and Radionuclide therapy. He interconnects Positron emission tomography and Metastasis in the investigation of issues within Pathology. His Biodistribution research is multidisciplinary, relying on both Pharmacokinetics and Pharmacology.
Philip J. Blower mostly deals with Positron emission tomography, Radiochemistry, Biodistribution, Pathology and Labelling. His research in Positron emission tomography intersects with topics in Molecular imaging, Hypoxia, Distribution and Scintigraphy. His work focuses on many connections between Distribution and other disciplines, such as Copper, that overlap with his field of interest in Combinatorial chemistry.
His Radiochemistry study combines topics from a wide range of disciplines, such as Chelation, Ex vivo, Specific activity and Radionuclide therapy. His biological study spans a wide range of topics, including Pharmacokinetics, Pharmacology, Liposome and Nuclear medicine. While the research belongs to areas of Cysteine, Philip J. Blower spends his time largely on the problem of Immunoconjugate, intersecting his research to questions surrounding Stereochemistry.
His scientific interests lie mostly in Biodistribution, Positron emission tomography, Nuclear medicine, Pathology and Tris. His Biodistribution study incorporates themes from Ex vivo, Pharmacokinetics, Pharmacology, Liposome and Radiochemistry. His studies in Positron emission tomography integrate themes in fields like Magnetic resonance imaging, Tomography, Hypoxia and Polyethylene glycol.
His work on Pet tracer and PET-CT is typically connected to Sodium-iodide symporter as part of general Nuclear medicine study, connecting several disciplines of science. His Tris research incorporates themes from Bifunctional, Chelation, DOTA and Peptide. His Chelation research is multidisciplinary, incorporating perspectives in Reactivity, Stereochemistry and Nuclear chemistry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Thiolato-complexes of the transition metals
Philip Blower;J R Dilworth.
Coordination Chemistry Reviews (1987)
Copper radionuclides and radiopharmaceuticals in nuclear medicine
Philip J. Blower;Philip J. Blower;Jason S. Lewis;Jamal Zweit.
Nuclear Medicine and Biology (1996)
Bisphosphonate-Anchored PEGylation and Radiolabeling of Superparamagnetic Iron Oxide: Long-Circulating Nanoparticles for in Vivo Multimodal (T1 MRI-SPECT) Imaging
Lydia Sandiford;Alkystis Phinikaridou;Andrea Protti;Levente K. Meszaros.
ACS Nano (2013)
Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships.
Jason L J Dearling;Jason S Lewis;Gregory E D Mullen;Michael J Welch.
Journal of Biological Inorganic Chemistry (2002)
Imaging tumour hypoxia with positron emission tomography.
Ian N Fleming;Roido Manavaki;Philip J Blower;Catharine West.
British Journal of Cancer (2015)
Studies on the mechanism of hypoxic selectivity in copper bis(thiosemicarbazone) radiopharmaceuticals.
Richard I. Maurer;Philip J. Blower;Jonathan R. Dilworth;Christopher A. Reynolds.
Journal of Medicinal Chemistry (2002)
Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.
Maggie S. Cooper;Michelle T. Ma;Kavitha Sunassee;Karen P. Shaw.
Bioconjugate Chemistry (2012)
99mTc-Bisphosphonate-Iron Oxide Nanoparticle Conjugates for Dual-Modality Biomedical Imaging
Rafael Torres Martin de Rosales;Richard Tavaré;Arnaud Glaria;Gopal Varma.
Bioconjugate Chemistry (2011)
Structural trends in copper(II) bis(thiosemicarbazone) radiopharmaceuticals
Philip J. Blower;Thomas C. Castle;Andrew R. Cowley;Jonathan R. Dilworth.
Dalton Transactions (2003)
Synthesis of 64CuII–Bis(dithiocarbamatebisphosphonate) and Its Conjugation with Superparamagnetic Iron Oxide Nanoparticles: In Vivo Evaluation as Dual‐Modality PET–MRI Agent
Rafael Torres Martin de Rosales;Richard Tavaré;Rowena L. Paul;Maite Jauregui-Osoro.
Angewandte Chemie (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: